Source:http://linkedlifedata.com/resource/pubmed/id/19135232
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2009-2-27
|
| pubmed:abstractText |
The optimal treatment regimen for advanced stage endometrial carcinoma (EC) is yet to be established. The objective of this study was to evaluate the feasibility and toxicity of delivering sequential doxorubicin-cisplatin (AC) followed by whole abdomen irradiation (WAI).
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
1095-6859
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
112
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
553-7
|
| pubmed:meshHeading |
pubmed-meshheading:19135232-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19135232-Cisplatin,
pubmed-meshheading:19135232-Combined Modality Therapy,
pubmed-meshheading:19135232-Disease-Free Survival,
pubmed-meshheading:19135232-Doxorubicin,
pubmed-meshheading:19135232-Endometrial Neoplasms,
pubmed-meshheading:19135232-Female,
pubmed-meshheading:19135232-Humans,
pubmed-meshheading:19135232-Neoplasm Staging,
pubmed-meshheading:19135232-Radiotherapy
|
| pubmed:year |
2009
|
| pubmed:articleTitle |
Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation.
|
| pubmed:affiliation |
The Ohio State University, Gynecologic Oncology, M210 Starling-Loving Hall, 320 West Tenth Avenue, Columbus, OH 43210-1228, USA. Jeffrey.Fowler@osumc.edu
|
| pubmed:publicationType |
Journal Article,
Clinical Trial, Phase I,
Research Support, N.I.H., Extramural
|